Two new compounds may be able to treat retinitis pigmentosa, a group of inherited eye diseases that cause blindness. The ...

A new study reveals the potential of two compounds in treating retinitis pigmentosa, a blinding genetic disorder. These compounds, identified through virtual screening, have shown promising results in ...

W orking with mammalian retinal cells, neuroscientists at Johns Hopkins Medicine have shown that unlike most light-sensing cells (photoreceptors) in the retina, one special type uses two different ...

Treatment with bioavailable small-molecule pharmacochaperones targeting the visual receptor rhodopsin offers a promising approach to prevent retinal photoreceptor degeneration caused by inherited ...

Two compounds prolonged the survival of photoreceptors in a retinitis pigmentosa mouse model for rod opsin misfolding ...

Two new compounds may be able to treat retinitis pigmentosa, a group of inherited eye diseases that cause blindness. The ...

The processing of optical information in the retina of the eye, where the light-sensitive photoreceptors and the first nerve ...

Based on in situ hybridization and hypothyroid studies, thyroid hormone appears to target photoreceptor development. The hormone may be acting in at least two ways. It could instruct neuronal ...

The light-detecting part of the retina is formed of rod and cone photoreceptor cells that are responsible for everything we see. The lower third of this image depicts the layer of blood vessels ...

The beautiful hues and plumes of birds have long drawn the attention and interest of mankind. But, do we really know the true ...

The FDA granted rare pediatric disease designation to VG901 for the treatment of retinitis pigmentosa caused by mutations in ...